
Umecrine Cognition
Developer of pharmaceutical drugs designed to treat cognitive neurological disorders. The company offers drugs for the treatment of symptoms in the central nervous system related to chronic neuroinfla...
Valuation
$0
Share Price
N/A
Total Raised
$28.1M
Last Round
N/A